Determining MSI status by a one-step PCR melting curve analysis of Chinese-specific mononucleotide repeats.

Authors

null

Huang Chen

China-Japan Friendship Hospital, Beijing, China

Huang Chen , Jianzheng Jie , Ruiying Jiang , Xiaowei Wang , Ye Wang , Qianqian Feng , Yun Niu , Bei Wang , Jie Luo , Wenqing Su , Youcai Li , Fei Gai , Roman Song , Changbin Zhu , Dingrong Zhong

Organizations

China-Japan Friendship Hospital, Beijing, China, Department of Translational Medicine, Amoy Diagnostics Co., Ltd., Xiamen, China, Department of Research and Development, Amoy Diagnostics Co., Ltd., Xiamen, China, China Japan Friendship Hospital, Beijing, China

Research Funding

No funding received
None.

Background: Microsatellite instability (MSI) is a hypermutated phenotype primarily caused by the deficiency of DNA mismatch repair activity. Conventional MSI detection platforms are time consuming and need extra normal tissue. Due to the short DNA sequences of microsatellite loci in MSI samples, the method can be simplified to a one-step approach to differentiate MSI status by observing the melting curve. Herein a novel feasible MSI status detection method based on one step-PCR in single tumor tissue was developed, and validated in colorectal cancer samples. Methods: Specific microsatellite sites shorter than 12 bp in length (feasibility of fluorescence probes) were selected from public databases for analysis. In tumor tissues from 98 CRC patients with known MSI status, microsatellite sites with the highest receiver operating characteristic (ROC)-area under the ROC curve (AUC) were eventually selected for the final PCR panel design. The cut-off value of this assay was defined by the number of melting peaks in a specific Tm value range. An independent set of 199 tumor tissues from CRC patients with known MSI by Sanger sequencing was recruited to validate the performance of this novel PCR MSI kit. Results: The ROC-AUCs of the pre-selected eight mononucleotide repeats were 0.82, 0.93, 0.79, 0.78, 0.98, 0.95, 0.92, and 0.79. When 0 or 1 marker had a melting peak within the specified Tm value range, the sample was identified as "MSS/MSI-low (MSI-L)"; when 2 or more markers had melting peaks within the specified Tm value range, the sample was determined to be "MSI-high (MSI-H)". In the clinical sample set, compared with the results given by conventional MSI detection method, the sensitivity of the 8-gene panel for MSI-H was 99.4% (166/167), the specificity of the 8-gene panel was 100%, and the overall concordance reached to 99.5%. Conclusions: The novel PCR-MSI detection method using 8-gene panel developed in this study was feasible and accessible in clinical practice, and a large-scale clinical validation is in progress.

Orthogonal analysis of the novel PCR MSI in 199 CRC samples.

PCR-melting curve
MSI-HMSS/MSI-L
Sanger sequencingMSI-H1661
MSS/MSI-L/32

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2023 ASCO Annual Meeting

Session Type

Publication Only

Session Title

Publication Only: Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Epidemiology/Outcomes

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr e15532)

DOI

10.1200/JCO.2023.41.16_suppl.e15532

Abstract #

e15532

Abstract Disclosures

Similar Abstracts

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Comprehensive analysis of differentially methylated regions in colorectal cancer (CRC).

First Author: Omid Solari

Abstract

2023 ASCO Gastrointestinal Cancers Symposium

Unique microbial biomarkers identified in Nigerian patients with colorectal cancer.

First Author: Miseker Abate